Skip to main content
RFAI
NASDAQ Real Estate & Construction

RF Acquisition Corp II Seeks Shareholder Nod to Push Business Combination Deadline to February 2027

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$11.07
Mkt Cap
$38.883M
52W Low
$10.17
52W High
$11.435
52W Position info
8.8% above low
Off High info
3.2% below high
Rel. Volume
Market data snapshot near publication time

RFAI is trading near its 52-week low of $10.17 (8.8% above the low).

Summary

RF Acquisition Corp II filed a preliminary proxy seeking shareholder approval to extend its business combination deadline by six months to February 15, 2027, as its current deadline of August 15, 2026 approaches. The SPAC, which has a going-concern warning, needs the extension to complete its pending merger with Nanyang Biologics.


Key Events · Corporate Governance and Compliance · RFAI

  • Extension Vote Set for August 2026

    Shareholders will vote on a proposal to extend the business combination deadline from August 15, 2026 to February 15, 2027, via six one-month extensions. Approval requires a two-thirds majority of votes cast.

  • Trust Amendment Eliminates $100K Withdrawal Right

    The proposed Trust Agreement amendment removes the company's ability to withdraw up to $100,000 from the trust for dissolution expenses, ensuring more funds go to public shareholders if the SPAC liquidates.

  • Redemption at ~$11.07 Per Share Offered

    Public shareholders can redeem shares at approximately $11.07 each, based on the trust value of $53.5 million as of the record date. The stock closed at $11.03 on the record date, making redemption slightly more attractive than selling.

  • Going-Concern Warning Adds Urgency

    The company's last 10-Q (May 7, 2026) disclosed substantial doubt about its ability to continue as a going concern, underscoring the critical need for the extension to avoid liquidation.


Analysis · RFAI · Real Estate & Construction

Facing a going-concern warning and a pending merger with Nanyang Biologics, RF Acquisition Corp II is asking shareholders to approve a six-month extension to complete its business combination. Without approval, the company faces liquidation on August 15, 2026. The proposal also eliminates the company's ability to withdraw up to $100,000 from the trust for dissolution expenses, maximizing funds for public shareholders but leaving the company reliant on outside sources for any wind-down costs. The vote is critical: failure means the SPAC dissolves and public shareholders get about $11.07 per share, while insiders lose their entire investment. The outcome hinges on whether enough public shareholders support the extension or choose to redeem now.

At the time of this filing, RFAI was trading at $11.07 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $38.9M. The 52-week trading range was $10.17 to $11.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RFAI - Latest Insights

RFAI
May 07, 2026, 4:32 PM EDT
Source: Wiseek News
Importance Score:
8
RFAI
May 07, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
RFAI
Mar 19, 2026, 5:07 PM EDT
Filing Type: F-4
Importance Score:
9
RFAI
Feb 11, 2026, 4:15 PM EST
Filing Type: 10-K
Importance Score:
9